Hot melt coating techniques in sustained release formulation and evaluation of water soluble drug

International Journal of Pharma and Bio Sciences

Volumn 2, Issue 1, 2011, Pages 273-282

  Chandrikapure, P L ^a   Wadher, K J ^a   Umekar, M J ^a  

^a India   (India)

Author keywords

Beeswax; Cetyl alcohol; Hot melt coating; Multiparticulate system; Sustained release

Indexed keywords

DICLOFENAC POTASSIUM; ETHYL CELLULOSE;

AQUEOUS SOLUTION; ARTICLE; DRUG COATING; DRUG RELEASE; DRUG SOLUBILITY; HOT MELT COATING; IN VITRO STUDY; SUSTAINED RELEASE FORMULATION;

EID: 84855317536     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Uhrich KE, Cannizzaro S.M, Langer RS, Shakesheff KM, Polymeric systems for controlled drug release. Chem. Rev. 99: 3181-3198, (1999).
2. Nishihata T, Hirotani Y, Yamazi A, Takahashi K, Yoshitomo H, Preliminary study on sustained-release particles prepared with hydrogenated soya phospholipids and cholesterol. Int J Pharm 42: 257-260, (1988).
3. G.S. Banker, Film coating theory and practice, J. Pharm. Sci., 55: 81-89, (1966).
4. Spitael J and Kinget R, Influence of solvent composition upon film-coating. Pharm. Acta Helv, 55: 157-160, (1980).
5. A.K. Doolittle, The Technology of Solvents and Plasticizers, Wiley, New York, NY, (1962).
6. Vidmar V, Jalsenjak I, Kondo T, Volume of waterfilled pores in the ethyl cellulose membrane and the permeability of microcapsules. Int. J. Pharm Pharmacol., 34:411-414, (1982).
7. Uno K, Arakawa M, Kondo T, and Donbrow M, Permeability of ethyl cellulose microcapsules towards phenobarbital, J Micro encapsulation, 1: 335- 341, (1984)
8. F.M. Sakr F, El-Dim Zin, E. Esmat and F.M. Hasheim, Release kinetics of some drugs from a suggested polymeric device, Acta Pharm. Technol., 33:31-34, (1987).
9. Benita S, Donbrow M, Dissolution rate control of the release kinetics of watersoluble compounds from ethyl cellulose film-type microcapsules, Int. J. Pharm, 12: 251-264, (1982).
10. Haznedar S, Dortunc B, Preparation and in vitro evaluation of eudragit microspheres containing acetazolamide, Int. J. Pharm. 269:131-140, (2004).
11. Wasvary EC, J.M., Cash, WD., 1985. Diclofenac sodium a potent inhibitor of prostaglandin synthetase. Biochem. Pharmacol. 24: 641-643.
12. Brogen RN, Heel RC, Pakes E, Speight T M, Avery G.S, Diclofenac sodium a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. 20: 24-48, (1980).
13. Fowler P D, Shadforth M F, Crook P R, John V A, Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long-term treatment of rheumatoid arthritis. Eur. J. Clin. Pharmacol. 25: 389- 394, (1983).
14. Willis J V, Kendall M J, Flinn R.M, Thornik D P, Welling P G, The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur. J. Clin. Pharmacol. 16: 405-410, (1979).
15. J.G. Hardman, L.E. Limbird (Eds.), Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 9th Edn The McGraw Hill Company, (1996).
16. Shan-Yang Lin, Kung-Hsu Lin, Mei-Jane Li, Micronized ethylcellulose used for designing a directly compressed timecontrolled disintegration tablet. J.controlled release. 70: 321-328, (2001).
17. Siepmann F, Hoffmann A, Leclercq B, Carlin, Siepmann J, How to adjust desired drug release patterns from ethylcellulose-coated dosage forms J.Control.Release 119: 182-189, (2007).
18. Neau SH, Howard MA, Claudius JS, Howard DR, The effect of the aqueous solubility of xanthine derivatives on the release mechanism from ethylcelluse matrix tablet. Int. J. Pharm. 179: 97- 105, (1999).
19. Katikaneni, PR, Upadrashta SM, Neau SH, Mitra AK, Ethylcellulose matrix controlled release tablets of water soluble drugs. Int. J. Pharm. 123: 119- 125, (1995).
20. S.M Upadrashta, P.R Katikaneni, G.A.Hileman, P.R. Keshary, Direct compression controlled release tablets using ethylcellulose matrices. Drug Dev. Ind. Pharm.1993, 19, pp.449-460.